Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
The trouble with TIGITs: How 'overenthusiasm' led to Big Pharma's risky $6B gamble
mergers and acquisitions
MedTech
Wojcicki prevails in 23andMe auction, with final $305M bid
Her $305 million offer topped the previous frontrunner, Regeneron, which bid $256 million to incorporate the DNA tester's assets in its R&D.
Conor Hale
Jun 16, 2025 10:40am
Medtronic adopts familiar name for its diabetes spinout: MiniMed
Jun 12, 2025 10:30am
BioNTech buys German mRNA vaccine peer CureVac in $1.2B deal
Jun 12, 2025 8:17am
Embattled Elevation is latest biotech to accept Concentra buyout
Jun 9, 2025 10:25am
Merck made $3B offer for MoonLake—and could revive interest: FT
Jun 3, 2025 9:25am
Lilly lands next-gen pain asset in $1B SiteOne acquisition
May 27, 2025 11:30am
